Financials • Property/Casualty Insurance, Rail, Energy & Equity Holdings • SIC 6331
$542.49 ▲ +0.53
(+0.10%)
MKT CAP: $1.16T • VOL: 4.48M
52W L $464 52W H $824,765
BRK-B // SEC EDGAR XBRL STANDARDIZED FINANCIAL STATEMENTS (FA <GO>)
| LINE ITEM (USD / %) | FY 2025
FILED 2026-03-02 | FY 2024
FILED 2026-03-02 | FY 2023
FILED 2026-03-02 | FY 2022
FILED 2025-02-24 | FY 2021
FILED 2024-02-26 |
|---|---|---|---|---|---|
| Revenue (Total Sales) | $371.44B | $371.43B | $364.48B | $302.02B | $276.19B |
| YoY Revenue Growth % | 0.0% | +1.9% | +20.7% | +9.3% | +12.5% |
| Gross Profit | — | — | — | — | — |
| Gross Margin % | — | — | — | — | — |
| Research & Development (R&D) | — | — | — | — | — |
| Operating Income (EBIT) | $82.46B | $110.38B | $120.17B | -$30.50B | $111.86B |
| Operating Margin % | 22.2% | 29.7% | 33.0% | -10.1% | 40.5% |
| Net Income (GAAP) | $66.97B | $89.00B | $96.22B | -$22.76B | $89.94B |
| EBITDA (Normalized) | $95.94B | $123.23B | $132.65B | -$19.60B | $122.58B |
| Diluted EPS ($/sh) | — | — | — | — | — |
| Operating Cash Flow (OCF) | $45.97B | $30.59B | $49.20B | $37.35B | $39.43B |
| Capital Expenditures (CapEx) | $20.93B | $18.98B | $19.41B | $15.46B | $13.28B |
| Free Cash Flow (FCF) | $25.04B | $11.62B | $29.79B | $21.89B | $26.15B |
| FCF Margin % | 6.7% | 3.1% | 8.2% | 7.3% | 9.5% |
| Return on Invested Capital (ROIC %) | 9.3% | 13.7% | 17.1% | -4.8% | 17.8% |
| Cash & Short-Term Equivalents | $52.57B | $48.38B | $38.64B | $36.40B | $88.71B |
| Total Debt (Short + Long Term) | — | — | — | — | — |
| Total Stockholders' Equity | $717.42B | $649.37B | $561.27B | $473.42B | $506.20B |
| LINE ITEM (USD / %) | Q2 2026
FILED 2026-08-10 | Q1 2026
FILED 2026-05-04 | Q4 2025
FILED 2026-03-02 | Q3 2025
FILED 2025-11-03 | Q2 2025
FILED 2026-08-10 | Q1 2025
FILED 2026-05-04 |
|---|---|---|---|---|---|---|
| Revenue (Total Sales) | $101.81B | $93.67B | $94.23B | $94.97B | $92.52B | $89.72B |
| YoY Revenue Growth % | +10.0% | +4.4% | -0.7% | +2.1% | -1.2% | -0.2% |
| Gross Profit | — | — | — | — | — | — |
| Gross Margin % | — | — | — | — | — | — |
| Research & Development (R&D) | — | — | — | — | — | — |
| Operating Income (EBIT) | $32.06B | $12.32B | $24.46B | $38.10B | $14.75B | $5.15B |
| Operating Margin % | 31.5% | 13.2% | 25.9% | 40.1% | 15.9% | 5.7% |
| Net Income (GAAP) | $25.67B | $10.11B | $19.20B | $30.80B | $12.37B | $4.60B |
| EBITDA (Normalized) | $35.67B | $15.83B | $26.90B | $41.44B | $18.08B | $8.41B |
| Diluted EPS ($/sh) | — | — | — | — | — | — |
| Operating Cash Flow (OCF) | $11.21B | $10.44B | $11.19B | $13.79B | $10.09B | $10.90B |
| Capital Expenditures (CapEx) | $5.64B | $4.99B | $6.20B | $5.59B | $4.86B | $4.28B |
| Free Cash Flow (FCF) | $5.57B | $5.45B | $4.99B | $8.20B | $5.23B | $6.62B |
| FCF Margin % | 5.5% | 5.8% | 5.3% | 8.6% | 5.7% | 7.4% |
| Return on Invested Capital (ROIC %) | 13.7% | 5.6% | 10.7% | 17.6% | 7.4% | 2.8% |
| Cash & Short-Term Equivalents | $41.36B | $58.81B | $52.57B | $77.11B | $101.23B | $42.85B |
| Total Debt (Short + Long Term) | — | — | — | — | — | — |
| Total Stockholders' Equity | $747.91B | $727.18B | $717.42B | $698.15B | $667.99B | $654.47B |